- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0002644

Zoofin Pharmaceuticals Private Limited
About Zoofin Pharmaceuticals Private Limited
Data last updated:
Zoofin Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 21 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304CH2018PTC042269. Its GSTIN is 06AABCZ2903K1ZB (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suman Verma and Inderjeet Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 2662 Ground Floor Sector 40C Near Dps School, Chandigarh, India – 160036.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.28 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹28,607 (net margin -22.4%) and EBITDA of -₹15,658 (EBITDA margin -12.3%). Revenue has declined at a compounded annual rate (CAGR) of 10% over five years.
Zoofin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0002644).
Company details
Recognitions & Rankings of Zoofin Pharmaceuticals
Contact details
Zoofin Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No 2662 Ground Floor Sector 40C Near Dps School, Chandigarh, India – 160036
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Zoofin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zoofin Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Zoofin Pharmaceuticals Private Limited, buy the company report.
Financials of Zoofin Pharmaceuticals Private Limited
FY 2025 filings availableZoofin Pharmaceuticals Private Limited reported revenue of ₹1.28 Lakh (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 15% fall in the latest year. EBITDA rose 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹15,658 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹28,607 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.3% | ||||
| Net Profit Margin | -22.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zoofin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zoofin Pharmaceuticals Private Limited
Zoofin Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Verma | Director | 21 Nov 2018 | 7 Years 11 Months | Current |
| Inderjeet Verma | Director | 21 Nov 2018 | 7 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Zoofin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zoofin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zoofin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AABCZ2903K1ZB | Haryana | Active | 20 Mar 2019 |
To see the full GST registrations and return filing status of Zoofin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zoofin Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Inderjeet Verma was appointed as Director on 21 Nov 2018.
Frequently asked questions
Zoofin Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 21 November 2018 (8+ years old) and is registered under CIN U24304CH2018PTC042269.
Zoofin Pharmaceuticals has 2 current directors:
- Suman Verma - Director
- Inderjeet Verma - Director
The latest financial statements of Zoofin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zoofin Pharmaceuticals is 06AABCZ2903K1ZB, registered in Haryana.
The CIN (Corporate Identification Number) of Zoofin Pharmaceuticals is U24304CH2018PTC042269. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zoofin Pharmaceuticals was incorporated on 21 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
Inderjeet Verma was appointed as Director on 21 Nov 2018. Suman Verma was appointed as Director on 21 Nov 2018.
Yes, Zoofin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0002644).
The registered office of Zoofin Pharmaceuticals is at House No 2662 Ground Floor Sector 40C Near Dps School, Chandigarh, India – 160036.
Zoofin Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.

